Mitsubishi UFJ Kokusai Asset Management Co. Ltd. Increases Stock Position in Medical Properties Trust, Inc. (NYSE:MPW)

Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its stake in Medical Properties Trust, Inc. (NYSE:MPW) by 119.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 193,861 shares of the real estate investment trust’s stock after acquiring an additional 105,549 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in Medical Properties Trust were worth $4,058,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in MPW. Van Hulzen Asset Management LLC raised its holdings in shares of Medical Properties Trust by 1.1% in the third quarter. Van Hulzen Asset Management LLC now owns 45,800 shares of the real estate investment trust’s stock valued at $896,000 after buying an additional 500 shares during the last quarter. Private Ocean LLC purchased a new stake in shares of Medical Properties Trust in the third quarter valued at about $50,000. IFP Advisors Inc raised its holdings in shares of Medical Properties Trust by 5.1% in the fourth quarter. IFP Advisors Inc now owns 10,350 shares of the real estate investment trust’s stock valued at $213,000 after buying an additional 503 shares during the last quarter. Ellis Investment Partners LLC raised its holdings in shares of Medical Properties Trust by 1.3% in the fourth quarter. Ellis Investment Partners LLC now owns 41,805 shares of the real estate investment trust’s stock valued at $869,000 after buying an additional 541 shares during the last quarter. Finally, Renaissance Group LLC raised its holdings in shares of Medical Properties Trust by 6.2% in the third quarter. Renaissance Group LLC now owns 11,561 shares of the real estate investment trust’s stock valued at $226,000 after buying an additional 671 shares during the last quarter. 72.14% of the stock is owned by hedge funds and other institutional investors.

In other news, Director Michael G. Stewart sold 4,800 shares of the business’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $21.27, for a total transaction of $102,096.00. Also, COO Emmett E. Mclean sold 100,000 shares of the business’s stock in a transaction dated Wednesday, January 8th. The stock was sold at an average price of $20.84, for a total transaction of $2,084,000.00. Following the transaction, the chief operating officer now owns 1,003,415 shares in the company, valued at $20,911,168.60. The disclosure for this sale can be found here. Insiders own 1.18% of the company’s stock.

Shares of Medical Properties Trust stock opened at $23.61 on Friday. Medical Properties Trust, Inc. has a 52-week low of $16.83 and a 52-week high of $23.76. The company has a quick ratio of 6.27, a current ratio of 9.45 and a debt-to-equity ratio of 1.00. The company’s 50-day simple moving average is $21.98 and its 200-day simple moving average is $20.11. The firm has a market cap of $12.19 billion, a price-to-earnings ratio of 27.45, a price-to-earnings-growth ratio of 3.20 and a beta of 0.58.

Medical Properties Trust (NYSE:MPW) last issued its quarterly earnings results on Thursday, February 6th. The real estate investment trust reported $0.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.09). Medical Properties Trust had a return on equity of 6.57% and a net margin of 43.86%. The firm had revenue of $256.44 million for the quarter, compared to analyst estimates of $263.35 million. During the same quarter last year, the firm earned $0.31 earnings per share. The company’s revenue was up 42.0% compared to the same quarter last year. Equities research analysts anticipate that Medical Properties Trust, Inc. will post 1.68 EPS for the current year.

MPW has been the subject of a number of research reports. TheStreet raised shares of Medical Properties Trust from a “c+” rating to a “b” rating in a report on Thursday, February 6th. Barclays set a $22.00 target price on shares of Medical Properties Trust and gave the company a “buy” rating in a report on Monday, October 21st. Robert W. Baird upped their target price on shares of Medical Properties Trust from $20.00 to $22.00 and gave the company a “neutral” rating in a report on Tuesday, January 14th. ValuEngine raised shares of Medical Properties Trust from a “sell” rating to a “hold” rating in a report on Tuesday, December 3rd. Finally, Mizuho upped their target price on shares of Medical Properties Trust from $25.00 to $26.00 and gave the company a “buy” rating in a report on Thursday, December 26th. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $21.59.

Medical Properties Trust Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Further Reading: What are gap-down stocks?

Want to see what other hedge funds are holding MPW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medical Properties Trust, Inc. (NYSE:MPW).

Institutional Ownership by Quarter for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.